patent for semaglutide Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. 💉 Demand GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Day 1, semaglutide patent expiry:

Gallbladder issues , including gallstones and inflammation, might develop during treatment

The complete restart dosing protocol This is the section that matters most

For most women, a gradual and sustainable approach to weight management is less likely to disrupt menstrual function than rapid or extreme weight loss

Everyone is different, however the most common side effects we see are nausea, vomiting, diarrhea and constipation

The result: habit work that feels like a game, not a chore, with tools built around GLP-1 care and safety

Rheumatoid arthritis requires prompt rheumatology referral and disease-modifying drugs such as methotrexate, with biological therapies for refractory cases